John Chuback, M.D., Monika Gloviczki, M.D., Emily Iker, M.D., and Mark Melin, M.D.

On today's Episode #23, Dr. Chuback, Dr. Iker, Dr. Gloviczki, and Dr. Melin welcomed ANDY DORAISWAMY, a Health Care and Human Life Scientist.

FROM HIS LINKED BIO:

Andy is focused on advancing health and human life. He enjoys bringing bold and innovative teams together to ideate and improve health. He is the founder and CEO of Koya Medical, a team dedicated to transforming venous and lymphatic disease. He also serves as Chairman and board director with an eye-care and urology health venture. 

Previously, he led Oculeve, a first-in-class health venture backed by NEA, Kleiner Perkins, and Versant to treat ocular disorders with a revolutionary neuromodulation platform. The company was acquired by Allergan Plc. Prior to this, Andy invented sight-restoring intraocular implants that have given sight to more than 6 million humans across the globe. This technology was acquired by Santen Pharmaceuticals and licensed to Bausch & Lomb (marketed as envista IOL). 

He is trained as a scientist with a specialization in biomedical applications to solve diseases and extend healthy human life.